Shattuck Labs, Inc. (STTK)
NGS · Common · CUSIP 82024L103
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for STTK and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
82024L103
Market Cap
Mid Cap
IPO
10/9/2020 · $17.00/share
Business: Shattuck Labs, Inc. is a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of cancer and autoimmune disease. Compounds derived from Shattuck’s ARC platform simultaneously inhibit checkpoint molecules and activate costimulatory molecules within a single therapeutic.

Company Contact

CEO
Taylor H. Schreiber
VPF
Andrew R. Neill
Headquarters
500 W. 5th Street, Suite 1200, Austin, TX 78701
Phone
512-900-4690
Investor Relations
Conor Richardson · 919-864-2700 · InvestorRelations@shattucklabs.com
SEC EDGAR Filings
View filings »